Home FDA labels 20657a0b-bb40-4402-950a-32112309ae6f FDA label 20657a0b-bb40-4402-950a-32112309ae6f openFDA label record# This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)
SPL set ID ad75f9c9-9003-4bf0-8ffe-c0011497cdce
SPL ID 20657a0b-bb40-4402-950a-32112309ae6f
Version 2
Effective date 2018-12-13
Source export date 2026-10-12
Source partition 6
Source file https://download.open.fda.gov/drug/label/drug-label-0006-of-0014.json.zip
Source object key raw/openfda/drug-label/2026-10-12/b25dad4aaef9c88f0e827394a34fbbd1ce7d71422fa46b5d1e123befad498c1d/drug-label-0006-of-0014.json.zip
Source manifest SHA-256 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run 20261013T011858Z
Imported at 2026-10-13 01:49:41 Harmonized identifier links# Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
Harmonized identifiers page 1 of 1 · 2 matching rows.
Adverse reactions cross-check# openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Adverse reactions sections page 1 of 1 · 2 matching rows.
adverse reactions ADVERSE REACTIONS The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: Burning Itching Irritation Dryness Folliculitis Hypertrichosis Acneiform Eruptions Hypopigmentation Perioral Dermatitis Allergic Contact Dermatitis Maceration of the Skin Secondary Infection Skin Atrophy Striae Miliaria
adverse reactions table <table width="85%"> <col width="25%" align="left" valign="top"/> <col width="40%" align="left" valign="top"/> <col width="35%" align="left" valign="top"/> <tbody> <tr styleCode="Toprule Botrule"> <td> <list listType="unordered"> <item> <caption/>Burning</item> <item> <caption/>Itching</item> <item> <caption/>Irritation</item> <item> <caption/>Dryness</item> <item> <caption/>Folliculitis</item> </list> </td> <td> <list listType="unordered"> <item> <caption/>Hypertrichosis</item> <item> <caption/>Acneiform Eruptions</item> <item> <caption/>Hypopigmentation</item> <item> <caption/>Perioral Dermatitis</item> <item> <caption/>Allergic Contact Dermatitis</item> </list> </td> <td> <list listType="unordered"> <item> <caption/>Maceration of the Skin</item> <item> <caption/>Secondary Infection</item> <item> <caption/>Skin Atrophy</item> <item> <caption/>Striae</item> <item> <caption/>Miliaria</item> </list> </td> </tr> </tbody> </table>
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.